Please assess the completion status of the following clinical trial:

Trial Title: Early Two-dose Measles Vaccination Trial

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Infants of 4½ months of age registered in the Bandim Health Project registration system and currently living in the Bandim Health Project areas: Bandim I, Bandim II, Belem, Mindará and Cuntum; and who received all three diphtheria-tetanus-pertussis vaccinations at least 4 weeks before enrollment~Exclusion Criteria:~* Severe illness requiring immediate hospitalisation

- Gender: ALL
- Minimum Age: 4 Months
- Maximum Age: 6 Months
- Healthy Volunteers: t

Study Arms:
- 1 (Type: ACTIVE_COMPARATOR): Standard titre Edmonston-Zagreb measles vaccine at 4½ and 9 months of age
- 2 (Type: ACTIVE_COMPARATOR): Standard titre Schwarz measles vaccine at 9 months of age
- 3 (Type: ACTIVE_COMPARATOR): Standard titre Edmonston-Zagreb measles vaccine at 9 months of age

Based on this trial design, predict the completion outcome and termination type (if applicable).